Shift-Work Sleep Disorder Clinical Trial
Official title:
The Effects of Lemborexant on the Ability to Sleep During Daytime: A Feasibility Study to Evaluate the Potential of Lemborexant to Treat Shift Work Disorder
This study aim to evaluate whether a dose of 5 mg of lemborexant, as compared to a placebo, may improve daytime recovery sleep, without producing lingering sleepiness during wakefulness, using a 3-day simulated night shift protocol in the lab under constant monitoring.
After being informed about the study and potential risks, all patients giving written informed conset will undergo 2 screening visits to determine eligibility for study entry. Selected participants will then stay twice in the lab (active treatment condition and placebo condition), each visit lasting approximately 4 days. Participants will stay awake across the night and sleep during the day. Only the experimental condition will be different between the two visits (lemborexant or placebo). These experimental visits will be double-blind, in counterbalanced order and separated by an interval of at least 2 weeks (washout period). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01672502 -
Fire Fighter Fatigue Management Program: Operation Fight Fatigue
|
N/A | |
Completed |
NCT02978053 -
Light Treatment to Shift-working Nurses
|
N/A | |
Completed |
NCT00786357 -
Sleep Enhancement Training Study for Experienced Shiftworkers
|
Phase 1 | |
Completed |
NCT00786266 -
Sleep Enhancement Training Study for Novice Shiftworkers
|
Phase 1 | |
Completed |
NCT00900159 -
Effects of Daytime Eszopiclone Administration in Shift Workers
|
N/A | |
Completed |
NCT01988129 -
Fire Fighter Fatigue Management Program: Operation Healthy Sleep
|
N/A | |
Terminated |
NCT03879044 -
Transcranial Direct Current Stimulation Therapy for Sleepiness Related to Shift Work Disorder (tDCS-SWORD)
|
N/A | |
Completed |
NCT02541747 -
Assessments in Stress and Quality of Sleep/Life in Night-shift Nurses and Doctors
|
Phase 4 | |
Completed |
NCT03153917 -
Biological Rhythms Impact of 12 Hours Shift Work
|
N/A | |
Recruiting |
NCT03956745 -
Biomarkers for Circadian Timing in Healthy Adults
|
||
Active, not recruiting |
NCT03980340 -
Breath Biomarkers for Sleep Loss and Circadian Timing
|
||
Completed |
NCT02901860 -
Shift Work and Risk of Cardio-vascular Disease
|
||
Completed |
NCT00078312 -
Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
|
Phase 3 | |
Recruiting |
NCT04693182 -
Health Promoting Work Schedules: The Effect of Abolishing Quick Returns
|
N/A | |
Not yet recruiting |
NCT03087435 -
Well-Being in Medical Residents in the HIBA
|
||
Terminated |
NCT01264913 -
Cardiometabolic Risk of Shiftwork
|
N/A | |
Completed |
NCT03813654 -
Sleep and Circadian Treatments for Shift Workers
|
N/A |